DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stock Has Average Price Target of $13.31 According to Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have earned a consensus rating of “Hold” from the fourteen research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $13.31.

A number of brokerages have issued reports on XRAY. Barclays raised their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a report on Monday, August 24th. Piper Sandler upped their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. BMO Capital Markets dropped their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a “market perform” rating for the company in a report on Thursday, September 17th. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a research note on Monday, August 10th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $8.74 on Friday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. DENTSPLY SIRONA has a fifty-two week low of $8.61 and a fifty-two week high of $14.76. The stock has a 50 day moving average price of $11.19 and a two-hundred day moving average price of $11.26. The company has a market capitalization of $1.74 billion, a P/E ratio of -3.18, a PEG ratio of 1.13 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million for the quarter, compared to analysts’ expectations of $889.93 million. During the same quarter last year, the business earned $0.52 earnings per share. The business’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Analysts expect that DENTSPLY SIRONA will post 1.4 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently made changes to their positions in the business. Blue Trust Inc. lifted its position in shares of DENTSPLY SIRONA by 10.8% during the 1st quarter. Blue Trust Inc. now owns 12,555 shares of the medical instruments supplier’s stock valued at $146,000 after buying an additional 1,226 shares in the last quarter. Oregon Public Employees Retirement Fund increased its holdings in DENTSPLY SIRONA by 3.3% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock worth $475,000 after acquiring an additional 1,300 shares in the last quarter. Huntington National Bank increased its holdings in DENTSPLY SIRONA by 68.3% in the 4th quarter. Huntington National Bank now owns 4,689 shares of the medical instruments supplier’s stock worth $54,000 after acquiring an additional 1,903 shares in the last quarter. Performa Ltd US LLC raised its stake in DENTSPLY SIRONA by 116.1% during the 4th quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock worth $49,000 after acquiring an additional 2,283 shares during the period. Finally, Eurizon Capital SGR S.p.A. bought a new stake in DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

Dentsply Sirona is a global dental products and technologies company that develops, manufactures and markets solutions for dental professionals, laboratories and patients. Its portfolio includes consumable products, dental equipment and digital technologies used in preventive, restorative, endodontic, orthodontic, implant and prosthetic dentistry.

The company offers dental treatment centers, imaging systems, CAD/CAM systems, intraoral scanners, milling and 3D-printing solutions, instruments, endodontic files and equipment, restorative materials, dental implants, prosthetic components and orthodontic products.